Dividend Adjusted Return
Nov 13, 2025 - Nov 13, 2026UNH 407.46 (+23.4%)
Healthcare 347.93 (+24.3%)
S&P 500 7561.67 (+11.6%)






Stock Rover estimates UnitedHealth Group’s intrinsic (fair) value at $379.52, against a recent price of $407.46, a margin of safety of -7%. Quantitative scores (0–100): Value 86, Quality 73, Growth 79, Sentiment 88. Analyst consensus: Strong Buy.







Fair Value | $379.52 | |
Margin of Safety | -7% |
Value Score 86 Value Score: Our value score looks at EV/EBITDA, P/E, P/S, P/TB (Price/Tangible Book) and EPS Predictability. P/S and P/TB are compared within a sector. Other metrics are compared across all stocks | Quality Score 73 Quality Score: Our quality score compares profitability and balance sheet metrics to find high quality companies using ROIC, Net Margin, Gross Margin, Interest Coverage, and Debt / Equity metrics. |
Growth Score 79 Growth Score: Our growth score looks at the 5 year history and the forward estimates for EBITDA, Sales, and EPS growth, ranking the best companies across all stocks. | Sentiment Score 88 Sentiment Score: Our sentiment score finds stocks in favor by analyzing Short Interest, returns in key periods over the last year, Price vs. 52-wk High, Days Since 52-wk High and MACD signals. |
| UNH | Industry | S&P 500 | |
|---|---|---|---|
| Value Score | 86 | 84 | 68 |
| Price / Earnings | 23.3 | 18.6 | 24.9 |
| Price / Sales | 0.8 | 0.4 | 3.5 |
| Price / Free Cash Flow | 16.2 | 11.9 | 35.4 |
| Price / Book | 3.7 | 2.4 | 5.6 |
| Price / Tangible Book | - | - | 361.3 |
| EV / EBITDA | 15.0 | 13.4 | 18.1 |
| EPS Predict. Pctl. | 82 | 66 | 71 |
| Piotroski F Score | 7 | 7 | 7 |
| 5‑Year P/E Range | 10.0 41.4 |
| 5‑Year P/B Range | 2.3 7.2 |
| 5‑Year P/S Range | 0.5 1.8 |
| UNH | Industry | S&P 500 | |
|---|---|---|---|
| Growth Score | 79 | 69 | 79 |
| Sales Growth | |||
| Sales Growth Next Year | 3.1% | 2.9% | 20.6% |
| Sales 1‑Year Chg (%) | 3.3% | 1.4% | 19.3% |
| Sales 3‑Year Avg (%) | 7.7% | 7.4% | 14.8% |
| Sales 5‑Year Avg (%) | 10.0% | 9.6% | 13.3% |
| EPS Growth | |||
| Next Yr. Growth Est. | 13.7% | 13.4% | 15.4% |
| EPS 1‑Year Chg (%) | -8.7% | 1.1% | 44.9% |
| EPS 3‑Year Avg (%) | -8.7% | -8.2% | 20.4% |
| EPS 5‑Year Avg (%) | 1.7% | 0.7% | 15.4% |






JNJ | Johnson & Johnson | $687,888 | 43.4 | 1.9% | 14.9% | 49.6% | -4% | 63 | 79 | 95 |
ABBV | AbbVie | $521,499 | 50.7 | 2.4% | 8.2% | 30.8% | 1% | 57 | 91 | 87 |
UNH | UnitedHealth Group | $365,093 | 23.3 | 2.3% | 7.9% | 25.8% | -7% | 86 | 79 | 73 |
MRK | Merck & Co | $364,264 | 149.3 | 2.3% | 4.1% | 63.7% | 1% | 61 | 77 | 64 |
MCK | McKesson | $127,326 | 28.4 | 0.3% | 14.7% | 30.8% | -21% | 79 | 76 | 71 |
CVS | CVS Health | $114,321 | 10.4 | 3.0% | 2.1% | 15.4% | 16% | 94 | 75 | 65 |
ELV | Elevance Health | $92,837 | 18.3 | 1.6% | 1.0% | 33.5% | 9% | 92 | 76 | 62 |
CI | Cigna Group | $78,260 | 13.1 | 2.1% | 5.1% | 12.1% | 24% | 94 | 87 | 67 |
HUM | Humana | $54,046 | 43.9 | 0.8% | 7.3% | 92.6% | -10% | 88 | 92 | 55 |
CNC | Centene | $35,283 | 24.5 | - | 3.5% | 97.5% | -4% | 90 | 46 | 53 |
MOH | Molina Healthcare | $10,893 | - | - | 0.0% | 51.3% | -6% | 77 | 63 | 48 |
OSCR | Oscar Health | $9,646 | 13.8 | - | -8.1% | 122.6% | 28% | 97 | 56 | 88 |
| UNH | Industry | S&P 500 | |
|---|---|---|---|
| Quality Score | 73 | 60 | 77 |
| Gross Margin | 19.8% | 10.9% | 33.2% |
| Operating Margin | 5.3% | 2.8% | 17.4% |
| Net Margin | 3.5% | 2.3% | 14.2% |
| Return on Assets | 5.3% | 4.7% | 14.1% |
| Return on Equity | 16.2% | 14.9% | 37.7% |
| ROIC | 11.2% | 9.8% | 24.1% |
| UNH | Industry | S&P 500 | |
|---|---|---|---|
| Sentiment Score | 88 | 73 | 71 |
| 5‑Day Return | 3.4% | 3.6% | 2.5% |
| 1‑Month Return | 7.9% | 5.6% | -3.1% |
| YTD Return | 25.9% | 23.7% | 11.3% |
| 1‑Year Return | 25.8% | 25.0% | 13.4% |
| 3‑Year Return | -20.0% | -11.3% | 77.8% |
| 5‑Year Return | -2.8% | -2.6% | 72.7% |
| Beta 1‑Year | 0.34 | 0.25 | 1.00 |






| UNH | Industry | |
|---|---|---|
| Forward Dividend Yield | 2.3% | 2.0% |
| Payout Ratio | 51.5% | 41.5% |
| TTM Yield | 2.2% | - |
| Fwd. Div. Per Share | $9.28 | $6.42 |
| Div. 1Y Chg (%) | 5.0% | - |
| Div. 3Y Avg (%) | 7.3% | - |
| Div. 5Y Avg (%) | 9.9% | - |
| Cons. Growth Years | 10+ | - |
| Div. Coverage Ratio | 1.9 | 2.7 |
| Current Ratio | 0.7 |
| Quick Ratio | 0.7 |
| Price | $407.46 |
| Net Cash Per Share | -$50.78 |
| Equity Per Share | $109.48 |
| Debt / Equity | 0.8 |
| Solvency Ratio | 11% |
| Interest Coverage | 6.1 |
| Short % of Float | 1.7% |
| Altman Z‑Score | 3.1 |
| Current Quarter EPS | |
|---|---|
# Up Last 30 days | 16.00 |
# Down Last 30 days | 6.00 |
Mean Estimate | 2.27 |
% Change (30 Days) | 8.10% |
| Next Quarter EPS | |
|---|---|
# Up Last 30 days | 9.00 |
# Down Last 30 days | 5.00 |
Mean Estimate | 8.17 |
% Change (30 Days) | 0.64% |
| Cur Qtr | Next Qtr | Cur Year | Next Year | |
|---|---|---|---|---|
| Latest | $2.27 | $8.17 | $20.52 | $23.33 |
| 30 Days Ago | $2.10 | $8.12 | $19.87 | $22.61 |
| 90 Days Ago | $2.14 | $8.12 | $19.81 | $22.44 |
| % Change (90 Days) | 6.4% | 0.5% | 3.6% | 4.0% |
| Surprise Type | Amount | Percent |
|---|---|---|
| Positive Quarters (> 2%) | 7 | 58.3% |
| Negative Quarters (< 2%) | 1 | 8.3% |
| In-Line Quarters (within 2%) | 4 | 33.3% |
| Surprise Type | Announce Date | Period End Date | Actual EPS | Est. EPS | Surprise (%) |
|---|---|---|---|---|---|
| Positive | 10/13/26 | 09/30/26 | $4.69 | $4.12 | 13.8% |
| Positive | 08/04/26 | 06/30/26 | $6.38 | $4.94 | 29.1% |
| Positive | 04/21/26 | 03/31/26 | $7.23 | $6.46 | 11.9% |
| In-Line | 01/15/26 | 12/31/25 | $2.11 | $2.09 | 1.0% |
| Positive | 10/21/25 | 09/30/25 | $2.92 | $2.75 | 6.2% |
| Negative | 07/29/25 | 06/30/25 | $4.08 | $4.84 | -15.7% |
| UNH | Industry | S&P 500 | |
|---|---|---|---|
| Best Monthly Return (5Y) | 35.2% | 30.0% | 9.6% |
| Worst Monthly Return (5Y) | -24.7% | -20.4% | -9.6% |
| Beta 1‑Year | 0.34 | 0.25 | 1.00 |
| Volatility 1‑Year | 0.35 | 0.29 | 0.13 |
| Volatility 1Y Pctl. | 35 | - | - |
| Max Drawdown 1‑Year | -26.7% | -27.2% | -8.8% |
| Max Drawdown 3‑Year | -61.4% | -55.3% | -18.7% |
| Max Drawdown 5‑Year | -61.4% | -58.2% | -24.6% |











CNC | Centene | 59 | 1.9% | - | -2.3% | 9.7% | 10.7% | 10.9% |
CVS | CVS Health | 50 | 5.4% | - | 2.2% | 6.7% | 6.5% | 8.1% |
CI | Cigna Group | 41 | 5.2% | -21.6% | 4.0% | 6.8% | 14.7% | 11.1% |
UNH | UnitedHealth Group | 23 | -0.4% | 76.1% | 3.1% | 3.3% | 7.7% | 10.0% |
ELV | Elevance Health | 14 | 1.4% | 17.9% | 2.5% | 3.6% | 6.2% | 8.5% |
CVS | CVS Health | 95 | 10.4 | 10.3 | 1.2 | 0.3 | 1.4 | 7.8 220.7 |
CNC | Centene | 86 | 24.5 | 12.9 | 1.3 | 0.2 | 1.6 | 3.7 - |
CI | Cigna Group | 77 | 13.1 | 8.9 | - | 0.3 | 1.8 | 8.5 31.0 |
ELV | Elevance Health | 68 | 18.3 | 14.2 | 16.9 | 0.5 | 2.1 | 10.7 27.4 |
UNH | UnitedHealth Group | 50 | 23.3 | 17.5 | 13.9 | 0.8 | 3.7 | 10.0 41.4 |
UNH | UnitedHealth Group | 95 | 19.8% | 5.3% | 3.5% | 12.3% 26.0% | 4.1% 9.0% |
ELV | Elevance Health | 77 | 0.0% | - | 2.6% | 11.1% 17.3% | 4.0% 6.5% |
CI | Cigna Group | 68 | 8.7% | 3.0% | 2.1% | 5.9% 15.2% | 0.3% 4.5% |
CVS | CVS Health | 59 | 14.2% | 3.6% | 2.6% | 0.6% 13.7% | 0.2% 4.3% |
CNC | Centene | 32 | 7.8% | 0.8% | 0.7% | -33.4% 12.5% | -8.0% 4.1% |
CNC | Centene | 68 | 0.7 | 4.0 | 1.2 | 18.8% | 5% | 2.4% |
CVS | CVS Health | 59 | 0.9 | 5.0 | 0.7 | 42.5% | 10% | 1.4% |
ELV | Elevance Health | 50 | 0.7 | 5.3 | - | 30.7% | 22% | 2.4% |
UNH | UnitedHealth Group | 32 | 0.8 | 6.1 | 0.7 | 42.6% | 11% | 1.7% |
CI | Cigna Group | 14 | 0.7 | 7.0 | 0.7 | 45.9% | 10% | 2.6% |
CVS | CVS Health | 90 | 3.0% | 3.0% | $89.35 | $2.66 | 1 | 30.8% |
CI | Cigna Group | 70 | 2.1% | 2.1% | $297.00 | $6.24 | 6 | 27.2% |
UNH | UnitedHealth Group | 50 | 2.3% | 2.2% | $407.46 | $9.28 | 10+ | 51.5% |
ELV | Elevance Health | 30 | 1.6% | 1.6% | $429.69 | $6.88 | 10+ | 29.1% |
CNC | Centene | - | - | - | $71.27 | - | - | - |
CNC | Centene | 90 | 3.5% | 7.9% | 21.2% | 73.2% | 97.5% | 0.47 | 0.45 | 91.3% |
ELV | Elevance Health | 79 | 1.0% | 8.4% | 8.4% | 24.4% | 33.5% | 0.29 | 0.35 | 95.3% |
UNH | UnitedHealth Group | 77 | 7.9% | 2.7% | 2.8% | 25.9% | 25.8% | 0.34 | 0.35 | 88.3% |
CI | Cigna Group | 70 | 5.1% | 7.4% | -0.1% | 9.7% | 12.1% | 0.08 | 0.26 | 93.4% |
CVS | CVS Health | 55 | 2.1% | -5.9% | -8.4% | 15.2% | 15.4% | -0.03 | 0.34 | 80.7% |





2026 Dividends | $9.17 |
12/07/26 | 12/15/26 | Regular | $2.32 |
09/14/26 | 09/22/26 | Regular | $2.32 |
06/15/26 | 06/23/26 | Regular | $2.32 |
03/09/26 | 03/17/26 | Regular | $2.21 |
2025 Dividends | $8.73 |
12/08/25 | 12/16/25 | Regular | $2.21 |
09/15/25 | 09/23/25 | Regular | $2.21 |
06/16/25 | 06/24/25 | Regular | $2.21 |
03/10/25 | 03/18/25 | Regular | $2.10 |
2024 Dividends | $8.18 |
12/09/24 | 12/17/24 | Regular | $2.10 |
09/16/24 | 09/24/24 | Regular | $2.10 |
06/17/24 | 06/25/24 | Regular | $2.10 |
03/08/24 | 03/19/24 | Regular | $1.88 |
2023 Dividends | $7.29 |
12/01/23 | 12/12/23 | Regular | $1.88 |
09/08/23 | 09/19/23 | Regular | $1.88 |
06/15/23 | 06/27/23 | Regular | $1.88 |
03/10/23 | 03/21/23 | Regular | $1.65 |
2022 Dividends | $6.40 |
12/02/22 | 12/13/22 | Regular | $1.65 |
09/09/22 | 09/20/22 | Regular | $1.65 |
06/16/22 | 06/28/22 | Regular | $1.65 |
Ex-Dividend Date | 12/07/26 |
Payment Date | 12/15/26 |
Amount | $2.32 |
Type | Regular |
Regular Dividend | $2.32 |
Forward Dividend Rate | $9.28 |
Forward Dividend Yield | 2.3% |
Trailing 12 Months Dividends | $9.06 |
Trailing 12 Months Yield | 2.2% |
Payout Ratio | 51.5 |
Dividend Coverage Ratio | 1.9 |
Consecutive Growth Years | 10+ |
3 Year Growth Rate | 7.3% |
5 Year Growth Rate | 9.9% |
10 Year Growth Rate | 14.0% |
Price / Earnings | 23.3 | 14.4 | 40.1 | 24.3 | 27.3 |
Price / Cash Flow | 14.1 | 14.5 | 33.9 | 17.2 | 14.6 |
Price / Book | 3.7 | 3.2 | 6.2 | 6.1 | 6.7 |
Price / Tangible Book | - | - | - | - | - |
Price / Sales | 0.8 | 0.7 | 1.5 | 1.5 | 1.6 |
EV / EBITDA | 15.0 | 11.7 | 22.0 | 14.9 | 17.2 |
Forward Dividend Yield | 2.3% | 2.7% | 1.4% | 1.3% | 1.3% |
Shareholder Yield | 3.5% | 5.8% | 2.0% | 2.6% | 2.4% |
Gross Margin | 19.8% | 19.7% | 22.9% | 25.0% | 24.2% |
Net Margin | 3.5% | 4.0% | 3.6% | 6.0% | 6.2% |
Return on Assets | 5.3% | 6.0% | 5.3% | 8.4% | 8.9% |
Return on Equity | 16.2% | 18.4% | 15.1% | 25.7% | 26.0% |
ROIC | 11.2% | 11.7% | 13.3% | 15.8% | 16.3% |
Additional data provided by Zacks, Intrinio, Quandl, Yodlee, IEX Cloud
UNH has performed nearly in line with its sector over the past year.
The Healthcare sector has outperformed the market by 12.7% in the past year.